Effect of Abdominal Wall Injections on Abdominal Pain
Oregon Health and Science University · NCT06121466
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–100 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 45
- US sites recruiting
- 2
- Study start
- January 1, 2023
- Record last updated
- September 2, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a prospective cohort study of outpatient adults with chronic abdominal wall pain receiving abdominal wall injections, as part of their usual care, with lidocaine. Subjects will be recruited at the outpatient gastroenterology clinic at OHSU.
Being studied: Abdominal wall injections with lidocaine 2%
Conditions: Anterior Cutaneous Nerve Entrapment Syndrome
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Localized abdominal wall pain
- Average daily pain (7-day recall) ≥ 3 on a scale of 0-10
- Suspected abdominal wall etiology for abdominal pain
- Positive Carnett's sign or pain near an incisional site
- 18 years of age or older
Exclusion Criteria
- Suspected visceral etiology for the abdominal pain
- Severe allergy to lidocaine
- Unwillingness or inability to provide informed consent
- Low probability of follow-up
- Abdominal wall hernia noted at the point of pain
- History of trigger point injections for abdominal pain
- Bleeding disorder
- Pregnancy, incarceration or decisionally impaired
Recruiting US locations
OHSU
Portland, OR 97239
Site contact: Sophia Lichenstein-Hill · 5034944373 · lichenst@ohsu.edu
Oregon Health Sciences University
Portland, OR 97239
Site contact: Oregon HS University · 5034944373 · lichenst@ohsu.edu
Study contacts (from the official record)
- Sophia Lichenstein-Hill, DNP · 5038801235 · lichenst@ohsu.edu
Similar studies in Oregon
All healthy volunteers studies in Oregon →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Bend, OR + 18 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingHealthy volunteersPhase 1/Phase 2
Immunogenicity of Yellow Fever Vaccine 17D in Adults With Prior 17D Vaccination
Oregon Health and Science University
- Location
- Portland, OR
- Eligibility basics
- Ages 20–49
- RecruitingHealthy volunteersEarly Phase 1
Monoferric for Prenatal Iron Deficiency
Oregon Health and Science University
- Location
- Portland, OR
- Eligibility basics
- Ages 18–65 · Women only
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Portland, OR + 55 other US sites
- Eligibility basics
- Ages 18–79